日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Yifei Sanjie Formula in improving the response to PD-1 blockade by lung cancer through the attenuation of the USP7-NR1H4-bile acid metabolism axis.

益飞三治方通过减弱 USP7-NR1H4-胆汁酸代谢轴来改善肺癌对 PD-1 阻断的反应。

Ren Yangzi, Li Yuanliang, Fang Chongkai, Chen Zhiqiang, Xiao Zhiwei

Correction to: Potentiating CD8(+) T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling

更正:通过抑制PCSK9促进LDLR介导的TCR再循环和信号传导,从而增强CD8(+) T细胞的抗肿瘤活性

Yuan, Juanjuan; Cai, Ting; Zheng, Xiaojun; Ren, Yangzi; Qi, Jingwen; Lu, Xiaofei; Chen, Huihui; Lin, Huizhen; Chen, Zijie; Liu, Mengnan; He, Shangwen; Chen, Qijun; Feng, Siyang; Wu, Yingjun; Zhang, Zhenhai; Ding, Yanqing; Yang, Wei